David S. Ivill is a partner in the law firm of McDermott Will & Emery LLP and is based in the Firm’s New York office. He is the partner-in-charge of the Health Industry Advisory practice in New York. David has extensive experience in statutory and regulatory issues affecting the provision of health care services, particularly with respect to New York State; his practice includes counseling with respect to operational and management issues, fraud and abuse, Medicaid Managed Care, compliance programs, as well as reimbursement matters, corporate practice of medicine issues and not-for-profit/tax-exempt matters. David also has significant experience working with federally qualified health centers and advising clients with respect to the 340B Federal Drug Pricing Program. He represents a range of health care providers including hospitals, physicians and rehabilitation agencies, as well as other health care entities including clinical laboratories and medical device manufacturers. David represents Patient Safety Organizations (PSO) and has developed some of the first PSOs in the country. He also has private equity and mergers and acquisitions experience.
David is listed in Best Lawyers in America and has been recognized by Chambers USA as one of the leading lawyers in his field. He is a member of the American Health Lawyers Association and the Bar of the City of New York.
Prior to practicing law, David was a podiatric surgeon specializing in foot and ankle reconstruction with a subspecialty in oteomyelitis of the lower extremity.
David received his B.S. from Westminster College, with honors, his podiatric medical degree from the Pennsylvania College of Podiatric Medicine. He completed his residency at St Joseph's Hospital in Philadelphia and an AO Fellowship (for reconstructive surgery and surgical intervention for infections) in Ravensburg, Germany. David received his J.D. from the New York University School of Law.
David frequently speaks on topics of interest to health care providers and manufacturers. These topics include corporate practice of medicine issues, New York regulatory law, Medicaid Managed Care, and fraud and abuse issues. He has spoken to physician groups, private corporations and medical trade associations, including AdvaMed.
While attending New York University School of Law, David served as an articles editor for the Review of Law & Social Change.
Education
- New York University School of Law, J.D.
- Pennsylvania College of Podiatric Medicine, D.P.M.
- Westminster College, B.S. (cum laude)
